A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data
However, a crucial limitation of the above studies is that the endpoint was pathologic (described as asymptomatic chronic pancreatitis), referring to histologic changes, rather than clinical 26
Disruptions in BBSome assembly or function can impair receptor signaling, leading to the hallmark features of BBS
GLP-1 Treatment Options and Ongoing Care PCOS Sisters offers GLP-1 treatment options designed specifically for women with PCOS and their unique metabolic and hormonal needs
This helps protect cells from damage caused by free radicals, contributing to overall health and longevity
Other notable greenlights this year include Bristol Myers Squibbs Cobenfy, the first novel therapeutic for schizophrenia in 35 years, and Madrigal Pharmaceuticals Rezdiffra, the first-ever treatment for MASH